Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
Recruiting
Phase 2
Interventional Study
Menopause
Perimenopause
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 40 – 60
- Sex
- Female
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 104 (estimated)
- Sponsor
- Washington State University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* designated female at birth
* 40-60 years of age
* able to give informed consent (no intellectual disability)
* stable pharmacotherapeutic regimen, no change in the past 3 months
* abstinent from regular cannabis use (\<1x/month) for past year, and willing to abstain from use f…
Contacts